Company Filing History:
Years Active: 2024-2025
Title: Nahida Parveen: Innovator in Immunotherapy
Introduction
Nahida Parveen is a prominent inventor based in Cambridge, GB. She has made significant contributions to the field of immunotherapy, particularly through her work on antibodies that target the Inducible T cell Co-Stimulator (ICOS). With a total of 2 patents, her innovations are paving the way for new therapeutic approaches in treating cancers.
Latest Patents
Nahida's latest patents focus on the development of anti-ICOS antibodies. These antibodies are designed to bind to ICOS, which plays a crucial role in modulating the immune response. Her therapeutic applications aim to adjust the ratio between regulatory T cells and effector T cells, thereby stimulating the immune system of patients. This innovative approach holds promise for enhancing cancer treatments. Additionally, her patents explore combinations of anti-ICOS antibodies with other drugs for immuno-oncology, further expanding the potential for effective cancer therapies.
Career Highlights
Nahida Parveen is currently associated with Kymab Limited, where she continues her groundbreaking research. Her work is characterized by a commitment to advancing the understanding of immune modulation and its applications in therapeutic settings.
Collaborations
Throughout her career, Nahida has collaborated with notable colleagues, including Richard Charles Alfred Sainson and Stephen John Arkinstall. These partnerships have contributed to the success and impact of her research in the field of immunotherapy.
Conclusion
Nahida Parveen's contributions to the development of anti-ICOS antibodies represent a significant advancement in immunotherapy. Her innovative work is set to make a lasting impact on cancer treatment and the broader field of immunology.